Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Use of micronuclei DNA from erythrocytes in early-stage colorectal cancer detection.
Authors
Xingyun Yao
School of Life Sciences, Westlake University; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China
Xingyun Yao , Haobo Sun , Jie Pan , Yurong Jiao , Xiangxing Kong , Chengcheng Liu , Fangchao Zhu , Fei Meng , Honghao Liang , Yanfei Cao , Jun Li , Xiaofei Gao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 25)
DOI
10.1200/JCO.2024.42.3_suppl.25
Abstract #
25
Poster Bd #
C6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Evaluating the potential of micronuclei DNA from erythrocytes for early detection or recurrence risk prediction of colorectal cancer.
First Author: Xingyun Yao
Poster
2024 ASCO Annual Meeting
The use of micronuclei DNA from erythrocytes for the detection of early-stage gastrointestinal cancers.
First Author: Haobo Sun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Detection of early-stage gastrointestinal cancers by micronuclei DNA from erythrocytes.
First Author: Haobo Sun
Poster
2024 ASCO Annual Meeting
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
First Author: Huiyan Luo